Loading...
Loading chart...




The current price of AVGR is 0 USD — it has increased 0 % in the last trading day.
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Wall Street analysts forecast AVGR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVGR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Avinger Inc revenue for the last quarter amounts to 1.65M USD, decreased -9.19 % YoY.
Avinger Inc. EPS for the last quarter amounts to -1.82 USD, decreased -37.67 % YoY.
Avinger Inc (AVGR) has 68 emplpoyees as of February 09 2026.
Today AVGR has the market capitalization of 3.64M USD.